laptop training solutions |
||||
|
News for 20-Jun-26 Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General |
The Best laptop training solutions websiteAll the laptop training solutions information you need to know about is right
here. Presented and researched by http://www.mdnewscast.net. We've searched
the information super highway far and wide to provide you with the
best laptop training solutions site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
laptop training solutions
There must be something of value for you here. laptop training solutions is one of our big interests and we are developing this website into a mega portal. We'd love you to bookmark us and come back one day. Soon we might well be the leading laptop training solutions website. But not yet, of course, which is why we're linking to some other laptop training solutions sites. Currently they're the best around, for both information and buying. So for all your laptop training solutions needs we suggest you visit them right now. You won't be sorry you did. We've done a lot of research in this field and can assure you that they're the best on the web for just what you're looking for. you don't need to search any further. Remember to come back to our humble site one day though, because soon we're going to take the crown as the best site for laptop training solutions. laptop training solutions
What determines which laptop training solutions sites attract advertisers? Sites whose audience demographics match those of the advertiser's customer base. For instance, companies who sell laptop training solutions to businesses, want to pitch their message to executives who making decisions in that area. To put it bluntly, the laptop training solutions advertiser wants to get their message to you, the consumer. That's why they use appropriate and appeal banners and links like those shown below. Once again, the laptop training solutions demographics of the Web are a key factor in determining whether this strategy works. It's vital to understand who uses the Internet and who visits the laptop training solutions sites. Although computer technology makes it possible to gather some very specific data about site visitors, some demographic information is best gathered by asking you for your feedback. That's why many websites require you to register. They're trying to figure out who you are and what your particular interest in laptop training solutions might be. a Cold; Starve a Tumor by: ARA Content
(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it. At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor. The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size. Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful. One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review. Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients. If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.
|
|||
|
http://www.medmeet.com/ |
||||
| Medical On the Net Drugestore On-the-Net Medical Presentations |